These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 10780856

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W, Bar-Shavit Z.
    J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
    [Abstract] [Full Text] [Related]

  • 23. Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF).
    Gao YH, Shinki T, Yuasa T, Kataoka-Enomoto H, Komori T, Suda T, Yamaguchi A.
    Biochem Biophys Res Commun; 1998 Nov 27; 252(3):697-702. PubMed ID: 9837769
    [Abstract] [Full Text] [Related]

  • 24. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
    Sun SG, Lau YS, Itonaga I, Sabokbar A, Athanasou NA.
    J Pathol; 2006 May 27; 209(1):114-20. PubMed ID: 16482498
    [Abstract] [Full Text] [Related]

  • 25. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
    Kanatani M, Sugimoto T, Sowa H, Kobayashi T, Kanzawa M, Chihara K.
    J Cell Physiol; 2004 Oct 27; 201(1):17-25. PubMed ID: 15281085
    [Abstract] [Full Text] [Related]

  • 26. Osteoprotegerin is expressed in colon carcinoma cells.
    Pettersen I, Bakkelund W, Smedsrød B, Sveinbjørnsson B.
    Anticancer Res; 2005 Oct 27; 25(6B):3809-16. PubMed ID: 16309167
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.
    Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR.
    Arthritis Rheum; 2000 Feb 27; 43(2):250-8. PubMed ID: 10693863
    [Abstract] [Full Text] [Related]

  • 29. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.
    Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T, Higashio K.
    Biochem Biophys Res Commun; 1998 Dec 18; 253(2):395-400. PubMed ID: 9878548
    [Abstract] [Full Text] [Related]

  • 30. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
    Si AI, Huang L, Xu J, Kumta SM, Wood D, Zheng MH.
    J Cell Biochem; 2003 Aug 15; 89(6):1154-63. PubMed ID: 12898514
    [Abstract] [Full Text] [Related]

  • 31. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC.
    J Cell Physiol; 2005 Jun 15; 203(3):573-82. PubMed ID: 15573398
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation.
    Hiruma Y, Hirai T, Tsuda E.
    Biochem Biophys Res Commun; 2011 Jun 10; 409(3):424-9. PubMed ID: 21586272
    [Abstract] [Full Text] [Related]

  • 34. Regulation of osteoclastogenesis by gap junction communication.
    Matemba SF, Lie A, Ransjö M.
    J Cell Biochem; 2006 Oct 01; 99(2):528-37. PubMed ID: 16639710
    [Abstract] [Full Text] [Related]

  • 35. TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis.
    Abu-Amer Y, Abbas S, Hirayama T.
    J Cell Biochem; 2004 Nov 15; 93(5):980-9. PubMed ID: 15389885
    [Abstract] [Full Text] [Related]

  • 36. Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.
    Shipman CM, Croucher PI.
    Cancer Res; 2003 Mar 01; 63(5):912-6. PubMed ID: 12615702
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone.
    Atkins GJ, Bouralexis S, Haynes DR, Graves SE, Geary SM, Evdokiou A, Zannettino AC, Hay S, Findlay DM.
    Bone; 2001 Apr 01; 28(4):370-7. PubMed ID: 11336917
    [Abstract] [Full Text] [Related]

  • 40. Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-kappaB ligand.
    Xu J, Tan JW, Huang L, Gao XH, Laird R, Liu D, Wysocki S, Zheng MH.
    J Bone Miner Res; 2000 Nov 01; 15(11):2178-86. PubMed ID: 11092398
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.